TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive In Brief: UCSD Recruits Mitchell From USC; Wade Wins Policy Fellowship; ASCO Honors Burchenal July 15, 1994
TCL Archive In Brief: Jack White Resigns As Director Of Howard Cancer Center; Roberson to Retire From Centers Program June 1, 1984
TCL Archive Phase III Trial of Avastin and Temozolomide Shows Reduced Risk of Cancer Progression November 30, 2012
